Atai Life Sciences: Capital Raise, Share Options, Cathy Wood And More On Biotech Psychedelics Leader Atai Life Sciences N.V. (NASDAQ: ATAI ) recently filed a registration statement with the Securities and Exchange Commission for capital raise of up to $300 million through the issuance of common shares, debt securities, warrants and units. As explained by Jason Najum on Microdose , by using a shelf registration process the company can sell securities from time to time and in one or more offerings. A shelf offering permits the registration of a new batch of shares without having to sell the entire issue at once. And the capital raise may be held for over a three-year period, all of which gives the company the flexibility to act quickly if good opportunities arise. One of the best-capitalized companies … Full story available on Benzinga.com